(Q36673983)

15 August 2017

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus (English)

1 reference

15 August 2017

0 references

1 reference

8

Robert C Bast

1 reference

15 August 2017

9

Karen Lu

1 reference

15 August 2017

Richard G Moore

1

1 reference

15 August 2017

Amy K Brown

2

1 reference

15 August 2017

M Craig Miller

3

1 reference

15 August 2017

Donna Badgwell

4

1 reference

15 August 2017

Zhen Lu

5

1 reference

15 August 2017

W Jeffrey Allard

6

1 reference

15 August 2017

C O Granai

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

21 May 2008

1 reference

15 August 2017

1 reference

15 August 2017

110

1 reference

15 August 2017

2

1 reference

15 August 2017

196-201

1 reference

15 August 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594093

Preoperative serum CA-125 levels in treating endometrial cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594093

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594093

Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594093

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594093

Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594093

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594093

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

20 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Tissue and serum CA125 expression in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

CA 125: a useful marker in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Is OVX1 a suitable marker for endometrial cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Role of serial tumor markers in the surveillance for recurrence in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

CA 125 levels in the preoperative assessment of advanced-stage uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.002

The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18495222

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2008.04.002

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

18495222

1 reference